Skip to main content
. Author manuscript; available in PMC: 2015 Nov 28.
Published in final edited form as: Vaccine. 2014 Feb 13;32(50):6847–6854. doi: 10.1016/j.vaccine.2014.01.096

Fig. 5.

Fig. 5

Serum content (μg/mL) of IgG anti-PA from samples (n=96 - 99) of vaccinated humans evaluated at Study Days 0, 28, 42 and 70. Each symbol represents mean (and 1 Standard Deviation) anti-PA content for each Arm, and measurement was after each sample within the Arm was serially diluted and evaluated on at least 3 occasions in order to reach internally consistent precision (<30% CV for multiple tests of the individual samples).